L Force
Overview
Explore the profile of L Force including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boixeda R, Campins L, Juanola J, Force L
Rev Clin Esp
. 2024 Apr;
220(8):526-529.
PMID: 38620449
No abstract available.
2.
Boixeda R, Campins L, Juanola J, Force L
Rev Clin Esp (Barc)
. 2020 Aug;
220(8):526-529.
PMID: 32836322
No abstract available.
3.
Obaid T, Salami A, Nweze N, Deleon M, Force L, Gorgun E, et al.
Colorectal Dis
. 2020 May;
22(11):1758.
PMID: 32473065
No abstract available.
4.
Salami A, Obaid T, Nweze N, Deleon M, Force L, Gorgun E, et al.
Colorectal Dis
. 2019 Nov;
22(5):513-520.
PMID: 31782601
Aim: The optimal treatment approach for adenocarcinoma of the rectosigmoid junction remains unclear. The aim of this work was to compare outcomes of neoadjuvant chemoradiation (NCR) and adjuvant chemotherapy (AC)...
5.
Llibre J, Montoliu A, Miro J, Domingo P, Riera M, Tiraboschi J, et al.
HIV Med
. 2019 Jan;
20(3):237-247.
PMID: 30688007
Objectives: The aim of the study was to assess the rates of discontinuation of integrase inhibitor regimens because of any neuropsychiatric adverse event (NPAE) and the factors associated with discontinuation....
6.
Fernandez-Sierra M, Rueda-Domingo M, Rodriguez-Del-Aguila M, Perez-Lozano M, Force L, Fernandez-Villa T, et al.
Epidemiol Infect
. 2018 Aug;
146(14):1870-1877.
PMID: 30070190
Early, conforming antibiotic treatment in elderly patients hospitalised for community-acquired pneumonia (CAP) is a key factor in the prognosis and mortality. The objective was to examine whether empirical antibiotic treatment...
7.
Vendrell E, Capdevila J, Barrufet P, Force L, Sauca G, Martinez E, et al.
Rev Esp Quimioter
. 2015 Apr;
28(2):92-7.
PMID: 25904516
Introduction: Little is known about the natural course of patients with chronic stable illnesses colonized with methicillin-resistant Staphylococcus aureus (MRSA). The aim is to determine the impact of MRSA colonization...
8.
Barrufet M, Vendrell E, Force L, Sauca G, Rodriguez S, Martinez E, et al.
Rev Esp Quimioter
. 2014 Sep;
27(3):190-5.
PMID: 25229374
Unlabelled: To determine the prevalence and risk factors (RF) for methicillin-resistant Staphylococcus aureus (MRSA) during stay in 1 acute care hospital (ACH) and 4 long-term care facilities (LTCF). After obtaining...
9.
Podzamczer D, Imaz A, Perez I, Viciana P, Valencia E, Curto J, et al.
J Antimicrob Chemother
. 2014 May;
69(9):2536-40.
PMID: 24833755
Objectives: To present clinical experience with a regimen including abacavir/lamivudine + darunavir/ritonavir in a cohort of HIV-1-infected patients. Methods: A retrospective, multicentre cohort study, including all consecutive adult HIV-1-infected patients...
10.
Manzardo C, Esteve A, Ortega N, Podzamczer D, Murillas J, Segura F, et al.
Clin Microbiol Infect
. 2012 Sep;
19(7):646-53.
PMID: 22967234
In this prospective, multicentre cohort study, we analysed specific prognostic factors and the impact of timing of highly active antiretroviral therapy (HAART) on disease progression and death among 625 human...